BUSINESS

More news
Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational antiviral drug Remdesivir in patients with severe coronavirus disease (COVID-19), during the outbreak of the coronavirus disease (COVID-19), in

Gilead Earnings Beat Street Estimates, Writedown Taken On Cancer Drug

Gilead Sciences Inc on Thursday said its first-quarter revenue rose 3%, helped by sales of HIV drug Biktarvy and COVID antiviral Veklury, but the company reported a net loss as it wrote down the value of its 2020 acquisition of Immunomedics following recent trial results for cancer drug Trodelvy.
IBTimes Logo

Twitter User Growth Rises Amid Musk Takeover

Twitter Inc reported stronger than expected user growth in what could be its last quarter as a public company after agreeing to a $44-billion buyout by billionaire Elon Musk.

Pages

IBT Spotlight

We Help Businesses Find B2B Service Providers They Can Trust.